Hepatocellular carcinoma: Epidemic and treatment

被引:7
作者
Allen J. [1 ]
Venook A. [1 ]
机构
[1] Div. of Gastrointestinal Oncology, UCSF School of Medicine, USCF Medical Center, San Francisco, CA 94115-1610
关键词
Hepatocellular Carcinoma; Tace; Milan Criterion; Epithelial Growth Factor Receptor; Serum Vascular Endothelial Growth Factor Level;
D O I
10.1007/s11912-004-0047-9
中图分类号
学科分类号
摘要
Hepatocellular carcinoma remains a worldwide epidemic. Survival rates are poor; however, oncologists are able to offer regional therapies to those patients who present with early disease. Prevention through vaccination remains a mainstay of this epidemic. New staging systems that incorporate important information about tumor characteristics and liver disease improve our ability to prognosticate and treat these patients. Copyright © 2004 by Current Science Inc.
引用
收藏
页码:177 / 183
页数:6
相关论文
共 66 条
  • [1] Incidence, Mortality and Prevalence Worldwide, (2001)
  • [2] Hepatitis B virus: A comprehensive strategy for eliminating transmission in the US through universal childhood vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP), Morbid. Mortal Weekly Rep., 40, (1991)
  • [3] SEER Cancer Statistics Review 1975-2000
  • [4] Rasi G., Pierimarchi P., Sinibaldi Vallebona P., Et al., Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma. HCC, Int. Immunopharmacol., 3, pp. 1169-1197, (2003)
  • [5] Yu M.C., Yuan J.M., Govindarajan S., Ross R.K., Epidemiology of hepatocellular carcinoma, Can. J. Gastroenterol., 8, pp. 703-709, (2000)
  • [6] Lee W., Hepatitis B infection, N. Engl. J. Med., 337, pp. 1733-1745, (1997)
  • [7] Maddrey W., Hepatitis B-an important public health issue, Clin. Lab., 47, pp. 51-55, (2001)
  • [8] El Sarag H.B., Hepatocellular carcinoma and Hepatitis C in the United States, Hepatology, pp. 574-583, (2002)
  • [9] Alter M.I., Epidemiology of hepatitis C, Hepatology, 26, SUPPL. 1, (1997)
  • [10] (2003)